NYSEARCA:XDIV Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (XDIV) Price, Holdings, & News $25.08 -0.37 (-1.45%) As of 08/1/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 (NYSEARCA:XDIV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get XDIV alerts:Sign Up Key Stats Today's Range$25.02▼$25.1850-Day Range$25.08▼$105.7352-Week Range$25.02▼$25.85Volume31,931 shsAverage Volume14,489 shsMarket Capitalization$5.27 millionAssets Under Management$34.02 millionDividend Yield0.00%Net Expense Ratio0.58%Aggregate RatingN/A ETF Overview Read More Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 ExpensesTypeXDIVLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.58%0.58%0.56%0.51%0.53%Other Expenses0.00%0.27%0.56%0.59%0.56%Total Expense0.58%0.65%0.76%0.74%0.73%Fee Waiver0.00%-0.23%-0.66%-0.71%-0.63%Net Expense0.58%0.62%0.63%0.58%0.60% Receive XDIV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 and its competitors with MarketBeat's FREE daily newsletter. Email Address XDIV ETF News HeadlinesXDIV: Suddenly, Canadian Dividend Stocks Look FantasticMay 12, 2025 | seekingalpha.comXDIV: A Quality Dividend Fund With Sector-Specific Risks And Limited Growth PotentialDecember 21, 2024 | seekingalpha.comElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. | Brownstone Research (Ad)State Street Instl US Equity SvcOctober 24, 2024 | morningstar.comMTouchstone Dividend Equity ASeptember 6, 2024 | morningstar.comMCullen High Dividend Equity RetailSeptember 4, 2024 | morningstar.comMSee More Headlines XDIV ETF - Frequently Asked Questions How have XDIV shares performed this year? Metaurus U.S. Equity Ex-Dividend Fund-Series 2027's stock was trading at $105.73 on January 1st, 2025. Since then, XDIV stock has decreased by 76.3% and is now trading at $25.08. How do I buy shares of Metaurus U.S. Equity Ex-Dividend Fund-Series 2027? Shares of XDIV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 own? Based on aggregate information from My MarketBeat watchlists, some other companies that Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 investors own include Toronto-Dominion Bank (TD), Meta Platforms (META), NVIDIA (NVDA), Perseus Mining (PRU), Shopify (SHOP), iShares S&P/TSX Canadian Dividend Aristocrats Index ETF Common Class (CDZ) and Alphabet (GOOG). Fund Details IssuerMetaurus Advisors Fund NameUS Equity EX Dividend Fund-Series 2027 Tax ClassificationPartnership Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:XDIV Inception Date2/15/2018 Fund ManagerRichard Sandulli, Jamie Greenwald, Donald M. Callahan, Sean A. Dillon WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkSolactive US Ex-Dividends Index Series 2027 CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings0 Fund Statistics Assets Under Management$34.02 million Average Daily Volume$2.68 thousand Discount/Premium-0.60% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorMetaurus Advisors LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeWilmington Trust Company Lead Market MakerVirtu Financial Miscellaneous Outstanding Shares210,000Beta1.09 These 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (NYSEARCA:XDIV) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredOut with the old (A.I.) - In with the new (E.I.)One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 Please log in to your account or sign up in order to add this asset to your watchlist. Share Metaurus U.S. Equity Ex-Dividend Fund-Series 2027 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
